Generic Drug Development: A Regulatory and Scientific Guide

Prijzen vanaf
25,96

Uitgelicht

VERGELIJK ALLE AANBIEDERS (3)

Beschrijving

Bol Are you navigating the complex world of generic drug development and approval?Generic Drug Development: A Regulatory and Scientific Guide is the most current comprehensive reference available for pharmaceutical industry professionals, regulatory affairs specialists, and graduate-level researchers who need practical, up-to-date guidance on bringing generic medicines to market globally.What this book covers: - The Complete ANDA Pathway - From initial patent strategy through FDA review, deficiency response, and final approval- Bioequivalence Science - In-depth analysis including the ICH M13A guideline and the M13B draft for additional strengths biowaivers- GDUFA III Commitments - How updated performance goals reshape generic drug review timelines and submission strategy- Global GMP Compliance - Essential frameworks across FDA 21 CFR Parts 210/211, EMA EudraLex Volume 4, and WHO GMP standards- Side-by-Side Regulatory Comparisons - Direct breakdowns of FDA vs EMA vs WHO vs ICH requirements across every major topic- Complex Generics - Technical guidance on inhalation, topical, liposomal, and drug-device combination products- Lifecycle Management - Post-approval changes, patent exclusivities, authorised generics, and biosimilars via the 351(k) pathway- Global Registration - WHO Prequalification, CDSCO, ANVISA, and multi-market registration strategy in a single volumeWhy this book stands out: Written at strict academic and professional standards, this guide integrates the most recent regulatory updates, including ICH M13A, ICH M13B draft guidance, GDUFA III performance data, and EMA product-specific bioequivalence guidance into a single professionally structured reference. Every chapter includes learning objectives, regulatory comparison tables, key points summaries, and fully cited scholarly references.Whether you are preparing an ANDA submission, designing a bioequivalence study, managing a global regulatory dossier, or building a career in pharmaceutical regulatory affairs, this book is your essential desk reference.Ideal for: Regulatory affairs professionals - ANDA applicants - Pharmaceutical scientists - Graduate students in pharmacy and pharmaceutical sciences - Quality assurance and GMP specialistsEquip yourself with the ultimate regulatory desk reference. Order your copy today.

Vergelijk aanbieders (3)

Shop
Prijs
Verzendkosten
Totale prijs
25,96
Gratis
25,96
Naar shop
Gratis Shipping Costs
25,96
Gratis
25,96
Naar shop
Gratis Shipping Costs
30,99
Gratis
30,99
Naar shop
Gratis Shipping Costs
Beschrijving (2)
Bol

Are you navigating the complex world of generic drug development and approval?Generic Drug Development: A Regulatory and Scientific Guide is the most current comprehensive reference available for pharmaceutical industry professionals, regulatory affairs specialists, and graduate-level researchers who need practical, up-to-date guidance on bringing generic medicines to market globally.What this book covers: - The Complete ANDA Pathway - From initial patent strategy through FDA review, deficiency response, and final approval- Bioequivalence Science - In-depth analysis including the ICH M13A guideline and the M13B draft for additional strengths biowaivers- GDUFA III Commitments - How updated performance goals reshape generic drug review timelines and submission strategy- Global GMP Compliance - Essential frameworks across FDA 21 CFR Parts 210/211, EMA EudraLex Volume 4, and WHO GMP standards- Side-by-Side Regulatory Comparisons - Direct breakdowns of FDA vs EMA vs WHO vs ICH requirements across every major topic- Complex Generics - Technical guidance on inhalation, topical, liposomal, and drug-device combination products- Lifecycle Management - Post-approval changes, patent exclusivities, authorised generics, and biosimilars via the 351(k) pathway- Global Registration - WHO Prequalification, CDSCO, ANVISA, and multi-market registration strategy in a single volumeWhy this book stands out: Written at strict academic and professional standards, this guide integrates the most recent regulatory updates, including ICH M13A, ICH M13B draft guidance, GDUFA III performance data, and EMA product-specific bioequivalence guidance into a single professionally structured reference. Every chapter includes learning objectives, regulatory comparison tables, key points summaries, and fully cited scholarly references.Whether you are preparing an ANDA submission, designing a bioequivalence study, managing a global regulatory dossier, or building a career in pharmaceutical regulatory affairs, this book is your essential desk reference.Ideal for: Regulatory affairs professionals - ANDA applicants - Pharmaceutical scientists - Graduate students in pharmacy and pharmaceutical sciences - Quality assurance and GMP specialistsEquip yourself with the ultimate regulatory desk reference. Order your copy today.

Amazon

Pagina's: 436, Paperback, Independently published


Productspecificaties

Merk Independently Published
EAN
  • 9798199593335
Maat


Prijshistorie

* Prijshistorie bevat geen data van Amazon, Amazon Marketplace.

Prijzen voor het laatst bijgewerkt op:

Uitgelichte Keuze
25,96
Naar shop